{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:29:14Z","timestamp":1791325754129,"version":"4.3.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Changzhou Municipal Health Commission Science and Technology Project","award":["QY202301"],"award-info":[{"award-number":["QY202301"]}]},{"name":"the Changzhou Science and Technology Plan Project","award":["CJ20243007"],"award-info":[{"award-number":["CJ20243007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10620-026-09824-7","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:13:06Z","timestamp":1773897186000},"page":"3558-3574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PODXL2 Promotes Cholangiocarcinoma Progression via Interactions with Ezrin and Activation of the MAPK\/ERK1\/2 and PI3K\/AKT Signaling Pathways"],"prefix":"10.1007","volume":"71","author":[{"given":"Yu","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijiao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"9824_CR1","first-page":"198","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME. Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin. 2023;73:198\u2013222.","journal-title":"CA Cancer J Clin."},{"key":"9824_CR2","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S2468-1253(21)00171-0","volume":"6","author":"AE Kam","year":"2021","unstructured":"Kam AE, Masood A, Shroff RT. Current and emerging therapies for advanced biliary tract cancers. Lancet Gastroenterol Hepatol. 2021;6:956\u2013969.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"9824_CR3","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1242\/jcs.037507","volume":"121","author":"JS Nielsen","year":"2008","unstructured":"Nielsen JS, McNagny KM. Novel functions of the CD34 family. J Cell Sci. 2008;121:3683\u20133692.","journal-title":"J Cell Sci."},{"key":"9824_CR4","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1681\/ASN.2008070782","volume":"20","author":"JS Nielsen","year":"2009","unstructured":"Nielsen JS, McNagny KM. The role of podocalyxin in health and disease. J Am Soc Nephrol. 2009;20:1669\u20131676.","journal-title":"J Am Soc Nephrol."},{"key":"9824_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1385\/IR:34:1:13","volume":"34","author":"SG Furness","year":"2006","unstructured":"Furness SG, McNagny K. Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis. Immunol Res. 2006;34:13\u201332.","journal-title":"Immunol Res."},{"key":"9824_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood.V87.1.1.1","volume":"87","author":"DS Krause","year":"1996","unstructured":"Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood. 1996;87:1\u201313.","journal-title":"Blood."},{"key":"9824_CR7","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1182\/blood.V75.12.2417.2417","volume":"75","author":"L Fina","year":"1990","unstructured":"Fina L, Molgaard HV, Robertson D et al. Expression of the CD34 gene in vascular endothelial cells. Blood. 1990;75:2417\u20132426.","journal-title":"Blood."},{"key":"9824_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1387\/ijdb.041957mt","volume":"49","author":"M Tavian","year":"2005","unstructured":"Tavian M, P\u00e9ault B. Embryonic development of the human hematopoietic system. Int J Dev Biol. 2005;49:243\u2013250.","journal-title":"Int J Dev Biol."},{"key":"9824_CR9","first-page":"1311","volume":"35","author":"TB Marvasti","year":"2019","unstructured":"Marvasti TB, Alibhai FJ, Weisel RD, Li RK. CD34(+) Stem cells: promising roles in cardiac repair and regeneration. Can J Cardiol. 2019;35:1311\u20131321.","journal-title":"Can J Cardiol."},{"key":"9824_CR10","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1002\/jcb.29571","volume":"121","author":"S Kapoor","year":"2020","unstructured":"Kapoor S, Shenoy SP, Bose B. CD34 cells in somatic, regenerative and cancer stem cells: Developmental biology, cell therapy, and omics big data perspective. J Cell Biochem. 2020;121:3058\u20133069.","journal-title":"J Cell Biochem."},{"key":"9824_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41698-025-01040-2","volume":"9","author":"M Hou","year":"2025","unstructured":"Hou M, Chen J, Jiang Y et al. Single-cell analysis reveals CD34(+)CD90(+) endothelial cells promote tumor metastasis in gallbladder cancer. NPJ Precis Oncol. 2025;9:242.","journal-title":"NPJ Precis Oncol."},{"key":"9824_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40364-024-00655-0","volume":"12","author":"R Huang","year":"2024","unstructured":"Huang R, Wang F, Zou W et al. Tumor endothelium-derived PODXL correlates with immunosuppressive microenvironment and poor prognosis in cervical cancer patients receiving radiotherapy or chemoradiotherapy. Biomark Res. 2024;12:106.","journal-title":"Biomark Res."},{"key":"9824_CR13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s10735-024-10253-x","volume":"55","author":"Y Ding","year":"2024","unstructured":"Ding Y, Wang X, Shu F, Pan K, Chen X, Liu Q. PODXL promotes malignant progression of hepatocellular carcinoma by activating PI3K\/AKT pathway. J Mol Histol. 2024;55:1107\u20131120.","journal-title":"J Mol Histol."},{"key":"9824_CR14","doi-asserted-by":"publisher","first-page":"7539","DOI":"10.1038\/s41598-024-57053-7","volume":"14","author":"N Le Tran","year":"2024","unstructured":"Le Tran N, Wang Y, Bilandzic M, Stephens A, Nie G. Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma. Sci Rep. 2024;14:7539.","journal-title":"Sci Rep."},{"key":"9824_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/cas.13864","volume":"110","author":"Q Zhi","year":"2019","unstructured":"Zhi Q, Chen H, Liu F et al. Podocalyxin-like protein promotes gastric cancer progression through interacting with RUN and FYVE domain containing 1 protein. Cancer Sci. 2019;110:118\u2013134.","journal-title":"Cancer Sci."},{"key":"9824_CR16","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1158\/0008-5472.CAN-18-3369","volume":"79","author":"BS Wong","year":"2019","unstructured":"Wong BS, Shea DJ, Mistriotis P et al. A direct podocalyxin-dynamin-2 interaction regulates cytoskeletal dynamics to promote migration and metastasis in pancreatic cancer cells. Cancer Res. 2019;79:2878\u20132891.","journal-title":"Cancer Res."},{"key":"9824_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265172","volume":"17","author":"K Taniuchi","year":"2022","unstructured":"Taniuchi K, Ueno M, Yokose T et al. Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients. PLoS One. 2022;17:e0265172.","journal-title":"PLoS One."},{"key":"9824_CR18","doi-asserted-by":"publisher","first-page":"9896","DOI":"10.1038\/s41598-021-89134-2","volume":"11","author":"A Eurola","year":"2021","unstructured":"Eurola A, Ristim\u00e4ki A, Mustonen H et al. Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer. Sci Rep. 2021;11:9896.","journal-title":"Sci Rep."},{"key":"9824_CR19","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.celrep.2018.06.092","volume":"24","author":"J Fr\u00f6se","year":"2018","unstructured":"Fr\u00f6se J, Chen MB, Hebron KE et al. Epithelial-mesenchymal transition induces podocalyxin to promote extravasation via Ezrin Signaling. Cell Rep. 2018;24:962\u2013972.","journal-title":"Cell Rep."},{"key":"9824_CR20","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-06-3575","volume":"67","author":"S Sizemore","year":"2007","unstructured":"Sizemore S, Cicek M, Sizemore N, Ng KP, Casey G. Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin. Cancer Res. 2007;67:6183\u20136191.","journal-title":"Cancer Res."},{"key":"9824_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/0113892029273682240111052317","volume":"25","author":"R Mu","year":"2024","unstructured":"Mu R, Chang M, Feng C et al. Analysis of the expression of PRDX6 in patients with hepatocellular carcinoma and its effect on the phenotype of hepatocellular carcinoma cells. Curr Genomics. 2024;25:2\u201311.","journal-title":"Curr Genomics."},{"key":"9824_CR22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2174\/0109298665330781240830042601","volume":"31","author":"W Ye","year":"2024","unstructured":"Ye W, Wang J, Zheng J, Jiang M, Zhou Y, Wu Z. Association between higher expression of Vav1 in hepatocellular carcinoma and unfavourable clinicopathological features and prognosis. Protein Pept Lett. 2024;31:706\u2013713.","journal-title":"Protein Pept Lett."},{"key":"9824_CR23","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2174\/0115665232308821240826075513","volume":"25","author":"L Qi","year":"2025","unstructured":"Qi L, Tan Y, Zhou Y et al. Proteogenomic identification and analysis of KIF5B as a prognostic signature for hepatocellular carcinoma. Curr Gene Ther. 2025;25:532\u2013545.","journal-title":"Curr Gene Ther."},{"key":"9824_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2174\/0113892029308243240709073945","volume":"26","author":"IP Gudivada","year":"2025","unstructured":"Gudivada IP, Amajala KC. Integrative bioinformatics analysis for targeting hub genes in hepatocellular carcinoma treatment. Curr Genomics. 2025;26:48\u201380.","journal-title":"Curr Genomics."},{"key":"9824_CR25","doi-asserted-by":"publisher","first-page":"27390","DOI":"10.1074\/jbc.M304204200","volume":"278","author":"CB Fieger","year":"2003","unstructured":"Fieger CB, Sassetti CM, Rosen SD. Endoglycan, a member of the CD34 family, functions as an L-selectin ligand through modification with tyrosine sulfation and sialyl Lewis x. J Biol Chem. 2003;278:27390\u201327398.","journal-title":"J Biol Chem."},{"key":"9824_CR26","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.4049\/jimmunol.181.2.1480","volume":"181","author":"SC Kerr","year":"2008","unstructured":"Kerr SC, Fieger CB, Snapp KR, Rosen SD. Endoglycan, a member of the CD34 family of sialomucins, is a ligand for the vascular selectins. J Immunol. 2008;181:1480\u20131490.","journal-title":"J Immunol."},{"key":"9824_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-94-017-7215-0_13","volume":"867","author":"A Nicolini","year":"2015","unstructured":"Nicolini A, Ferrari P, Rossi G. Mucins and cytokeratins as serum tumor markers in breast cancer. Adv Exp Med Biol. 2015;867:197\u2013225.","journal-title":"Adv Exp Med Biol."},{"key":"9824_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110091","volume":"118","author":"G Zhang","year":"2023","unstructured":"Zhang G, Zheng G, Zhang H, Qiu L. MUC1 induces the accumulation of Foxp3(+) Treg cells in the tumor microenvironment to promote the growth and metastasis of cholangiocarcinoma through the EGFR\/PI3K\/Akt signaling pathway. Int Immunopharmacol. 2023;118:110091.","journal-title":"Int Immunopharmacol."},{"key":"9824_CR29","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.7150\/ijms.46125","volume":"17","author":"YY Lin","year":"2020","unstructured":"Lin YY, Wang CY, Phan NN et al. PODXL2 maintains cellular stemness and promotes breast cancer development through the Rac1\/Akt pathway. Int J Med Sci. 2020;17:1639\u20131651.","journal-title":"Int J Med Sci."},{"key":"9824_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/ijms22126303","volume":"22","author":"Y Soejima","year":"2021","unstructured":"Soejima Y, Takeuchi M, Miyamoto N, Sawabe M, Fukusato T. ITGB6-knockout suppresses cholangiocarcinoma cell migration and invasion with declining PODXL2 expression. Int J Mol Sci. 2021;22:50.","journal-title":"Int J Mol Sci."},{"key":"9824_CR31","doi-asserted-by":"publisher","first-page":"9001","DOI":"10.1074\/jbc.275.12.9001","volume":"275","author":"C Sassetti","year":"2000","unstructured":"Sassetti C, Van Zante A, Rosen SD. Identification of endoglycan, a member of the CD34\/podocalyxin family of sialomucins. J Biol Chem. 2000;275:9001\u20139010.","journal-title":"J Biol Chem."},{"key":"9824_CR32","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/BF02623562","volume":"25","author":"M Miyagiwa","year":"1989","unstructured":"Miyagiwa M, Ichida T, Tokiwa T, Sato J, Sasaki H. A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19\/9 in serum-free medium. In Vitro Cell Dev Biol. 1989;25:503\u2013510.","journal-title":"In Vitro Cell Dev Biol."},{"key":"9824_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.107064","volume":"51","author":"M Qurashi","year":"2025","unstructured":"Qurashi M, Vithayathil M, Khan SA. Epidemiology of cholangiocarcinoma. Eur J Surg Oncol. 2025;51:107064.","journal-title":"Eur J Surg Oncol."},{"key":"9824_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70210","volume":"39","author":"Y Su","year":"2025","unstructured":"Su Y, Zhou L, Yu Q, Liu W, Liu W. Silencing of PODXL2 Modulates Cell Viability and Tumor Immune Microenvironment of Prostate Cancer and Involves PI3K\/AKT Pathway Inactivation. J Biochem Mol Toxicol. 2025;39:e70210.","journal-title":"J Biochem Mol Toxicol."},{"key":"9824_CR35","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3390\/molecules30051018","volume":"30","author":"A Markowska","year":"2025","unstructured":"Markowska A, Markowska J, Stanis\u0142awiak-Rudowicz J, Kozak K, Roubinek OK, Jasi\u0144ska M. The role of ferulic acid in selected malignant neoplasms. Molecules. 2025;30:1018.","journal-title":"Molecules."},{"key":"9824_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/ijms23010146","volume":"23","author":"S Niland","year":"2021","unstructured":"Niland S, Riscanevo AX, Eble JA. Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression. Int J Mol Sci. 2021;23:146.","journal-title":"Int J Mol Sci."},{"key":"9824_CR37","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.3390\/ijms23063246","volume":"23","author":"K Kawaguchi","year":"2022","unstructured":"Kawaguchi K, Asano S. Pathophysiological roles of actin-binding scaffold protein, ezrin. Int J Mol Sci. 2022;23:3246.","journal-title":"Int J Mol Sci."},{"key":"9824_CR38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrm2866","volume":"11","author":"RG Fehon","year":"2010","unstructured":"Fehon RG, McClatchey AI, Bretscher A. Organizing the cell cortex: the role of ERM proteins. Nat Rev Mol Cell Biol. 2010;11:276\u2013287.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"9824_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.semcdb.2019.11.017","volume":"102","author":"JL Gallop","year":"2020","unstructured":"Gallop JL. Filopodia and their links with membrane traffic and cell adhesion. Semin Cell Dev Biol. 2020;102:81\u201389.","journal-title":"Semin Cell Dev Biol."},{"key":"9824_CR40","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1091\/mbc.e02-07-0410","volume":"14","author":"P Pujuguet","year":"2003","unstructured":"Pujuguet P, Del Maestro L, Gautreau A, Louvard D, Arpin M. Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol Biol Cell. 2003;14:2181\u20132191.","journal-title":"Mol Biol Cell."},{"key":"9824_CR41","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1242\/jcs.112.18.3081","volume":"112","author":"S Hiscox","year":"1999","unstructured":"Hiscox S, Jiang WG. Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin\/beta-catenin. J Cell Sci. 1999;112:3081\u20133090.","journal-title":"J Cell Sci."},{"key":"9824_CR42","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.12659\/MSM.906945","volume":"24","author":"P Liu","year":"2018","unstructured":"Liu P, Yang P, Zhang Z, Liu M, Hu S. Ezrin\/NF-\u03baB pathway regulates EGF-induced epithelial-mesenchymal transition (EMT), metastasis, and progression of osteosarcoma. Med Sci Monit. 2018;24:2098\u20132108.","journal-title":"Med Sci Monit."},{"key":"9824_CR43","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.molmed.2025.01.008","volume":"31","author":"A De Santis","year":"2025","unstructured":"De Santis A, Zhu L, Tao J, Rei\u00dffelder C, Sch\u00f6lch S. Molecular subtypes of intrahepatic cholangiocarcinoma. Trends Mol Med. 2025;31:755\u2013769.","journal-title":"Trends Mol Med."},{"key":"9824_CR44","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1097\/01.ASN.0000135968.49899.E8","volume":"15","author":"S Schmieder","year":"2004","unstructured":"Schmieder S, Nagai M, Orlando RA, Takeda T, Farquhar MG. Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells. J Am Soc Nephrol. 2004;15:2289\u20132298.","journal-title":"J Am Soc Nephrol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09824-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-09824-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09824-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T03:00:52Z","timestamp":1787540452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-09824-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["9824"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-09824-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to address a spacing error in the abstract","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study design and methodology received formal ethical authorization from the Ethics Review Board of the Third Affiliated Hospital of Soochow University (Authorization Reference: (2025) Science No. 009).","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript has received approval for publication from all listed authors.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}